NovaBay Pharmaceuticals Inc (NBY) — Financial Flexibility Index
NovaBay Pharmaceuticals Inc (NBY) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-2.27 Million (operating CF $-2.27 Million minus capex $0.00) represents 0% of total liabilities ($31.86 Million). Check NovaBay Pharmaceuticals Inc (NBY) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NovaBay Pharmaceuticals Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for NovaBay Pharmaceuticals Inc across 21 annual periods. See NBY working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for NovaBay Pharmaceuticals Inc (2005–2025)
Year-by-year free cash flow to debt coverage for NovaBay Pharmaceuticals Inc. For the full company profile including market capitalisation, see NovaBay Pharmaceuticals Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $-8.43 Million | $31.86 Million | ▲ +81.8% |
| 2024 | -1.46x | $-5.18 Million | $-5.18 Million | $3.55 Million | ▼ -96.5% |
| 2023 | -0.74x | $-4.24 Million | $-4.26 Million | $5.72 Million | ▲ +33.7% |
| 2022 | -1.12x | $-6.54 Million | $-6.65 Million | $5.84 Million | ▼ -69.1% |
| 2021 | -0.66x | $-9.14 Million | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.61x | $-4.70 Million | $-4.72 Million | $2.92 Million | ▼ -108.3% |
| 2019 | -0.77x | $-7.91 Million | $-7.93 Million | $10.25 Million | ▲ +38.4% |
| 2018 | -1.25x | $-5.52 Million | $-5.57 Million | $4.41 Million | ▼ -55.7% |
| 2017 | -0.81x | $-6.03 Million | $-6.27 Million | $7.49 Million | ▲ +44.3% |
| 2016 | -1.45x | $-11.97 Million | $-12.13 Million | $8.28 Million | ▲ +20.2% |
| 2015 | -1.81x | $-18.44 Million | $-18.56 Million | $10.18 Million | ▲ +31.2% |
| 2014 | -2.63x | $-14.99 Million | $-15.05 Million | $5.69 Million | ▼ -46.5% |
| 2013 | -1.80x | $-12.83 Million | $-12.97 Million | $7.13 Million | ▼ -46.2% |
| 2012 | -1.23x | $-6.38 Million | $-6.53 Million | $5.19 Million | ▼ -169.4% |
| 2011 | -0.46x | $-3.02 Million | $-3.14 Million | $6.62 Million | ▼ -202.9% |
| 2010 | 0.44x | $2.23 Million | $2.03 Million | $5.03 Million | ▲ +302.2% |
| 2009 | -0.22x | $-917.00K | $-1.65 Million | $4.18 Million | ▲ +84.4% |
| 2008 | -1.41x | $-9.33 Million | $-9.94 Million | $6.62 Million | ▼ -141.2% |
| 2007 | -0.58x | $-5.61 Million | $-6.27 Million | $9.60 Million | ▼ -215.0% |
| 2006 | 0.51x | $5.11 Million | $4.74 Million | $10.05 Million | ▲ +105.1% |
| 2005 | -10.02x | $-3.11 Million | $-3.23 Million | $310.00K | — |